Fundamental and Advanced Therapies, Vaccine Development against SARS-CoV-2

Number of the records: 1

Title	Fundamental and Advanced Therapies, Vaccine Development against SARS-CoV-2
Author	Hudakova Nikola Kulkarni Amod SAVNEIMU - Neuroimunologický ústav SAV ^ORCID
	Bhide Mangesh SAVNEIMU - Neuroimunologický ústav SAV ^ORCID
	Kontseková Eva SAVNEIMU - Neuroimunologický ústav SAV ^SCOPUS
	Čížková Dáša 1964 SAVNEIMU - Neuroimunologický ústav SAV ^ORCID

Co-authors	Hricikova Simona
Source document	Pathogens. Vol. 10, no. 6 (2021), art. no. 636
Language	eng - English
Country	CH - Switzerland
Document kind	rozpis článkov z periodík (rbx)
Citations	MARK, C. - GUPTA, S. - PUNNETT, A. - UPTON, J. - ORKIN, J. - ATKINSON, A. - CLARKE, L. - HEISEY, A. - MCGOVERN, C. - ALEXANDER, S. Safety of administration of BNT162b2 mRNA (Pfizer-BioNTech) COVID-19 vaccine in youths and young adults with a history of acute lymphoblastic leukemia and allergy to PEG-asparaginase. In PEDIATRIC BLOOD & CANCER. ISSN 1545-5009, NOV 2021, vol. 68, no. 11. Dostupné na: https://doi.org/10.1002/pbc.29295.
Category	ADMA - Scientific papers in foreign impacted journals registered in Web of Sciences or Scopus
Category of document (from 2022)	V3 - Vedecký výstup publikačnej činnosti z časopisu
Type of document	článok
Year	2021
Registered in	WOS
Registered in	SCOPUS
DOI	10.3390/pathogens10060636

article

	File name	Access	Size	Downloaded	Type	License
	Fundamental and Advanced Therapies, Vaccine Development against SARS-CoV-2.pdf	available	1.7 MB	3	Author's preprint

rok	CC	IF	IF Q (best)	JCR Av Jour IF Perc	SJR	SJR Q (best)	CiteScore
	N

rok vydania	rok metriky	IF	IF Q (best)	SJR	SJR Q (best)
2021	2020	3.492	Q2	0.984	Q2

Number of the records: 1